Details for New Drug Application (NDA): 217059
✉ Email this page to a colleague
NDA 217059 describes LEVETIRACETAM IN SODIUM CHLORIDE, which is a drug marketed by B Braun Medical Inc, Baxter Hlthcare Corp, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hq Spclt Pharma, and Nexus, and is included in eight NDAs. It is available from ten suppliers. Additional details are available on the LEVETIRACETAM IN SODIUM CHLORIDE profile page.
The generic ingredient in LEVETIRACETAM IN SODIUM CHLORIDE is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
The generic ingredient in LEVETIRACETAM IN SODIUM CHLORIDE is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 217059
| Tradename: | LEVETIRACETAM IN SODIUM CHLORIDE |
| Applicant: | Baxter Hlthcare Corp |
| Ingredient: | levetiracetam |
| Patents: | 0 |
Pharmacology for NDA: 217059
| Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 217059
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 217059 | ANDA | Baxter Healthcare Corporation | 36000-352 | 36000-352-40 | 24 BAG in 1 CARTON (36000-352-40) / 100 mL in 1 BAG (36000-352-01) |
| LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 217059 | ANDA | Baxter Healthcare Corporation | 36000-354 | 36000-354-40 | 24 BAG in 1 CARTON (36000-354-40) / 100 mL in 1 BAG (36000-354-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 500MG/100ML (5MG/ML) | ||||
| Approval Date: | Oct 2, 2023 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 1GM/100ML (10MG/ML) | ||||
| Approval Date: | Oct 2, 2023 | TE: | AP | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 1.5GM/100ML (15MG/ML) | ||||
| Approval Date: | Oct 2, 2023 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
